ANTISENSE PHARMA RAISES $ 18 MILLION IN VENTURE FINANCING

Antisense Pharma announces today that it has raised $ 18.0 million in private equity from the German MIG funds. This investment further validates Antisense Pharma's worldwide leadership in the field of antisense technology and its application, the development of targeted anticancer drugs.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-30-2005/0004225106&EDATE=)